ADAM17 and Vascular Function in Diabetes

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

February 3, 2025

Study Completion Date

November 1, 2025

Conditions

Diabetes Mellitus, Type 2

Interventions

DIETARY_SUPPLEMENT

Placebo

4 weeks of placebo supplements

DIETARY_SUPPLEMENT

Phosphatidylserine

4 weeks of phosphatidylserine supplements

Trial Locations (1)

University of Missouri- NextGen Clinical Translational Science Unit, Columbia

All Listed Sponsors

lead

University of Missouri-Columbia

OTHER

NCT04557228 - ADAM17 and Vascular Function in Diabetes | Biotech Hunter | Biotech Hunter